Top 25 Journals in Immunology Ranked by Web of Science (WOS) – 2024
- May 4, 2024
- Posted by: IRP Academy
- Category: Journals
List of Top Most Immunology Journals Ranked by WoS
Journal name | ISSN | 2022 JIF |
NATURE REVIEWS IMMUNOLOGY | 1474-1733 | 100.3 |
NATURE IMMUNOLOGY | 1529-2908 | 30.5 |
Annual Review of Immunology | 0732-0582 | 29.7 |
Science Immunology | 2470-9468 | 24.8 |
Cellular & Molecular Immunology | 1672-7681 | 24.1 |
TRENDS IN IMMUNOLOGY | 1471-4906 | 16.8 |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 0091-6749 | 14.2 |
Cancer Immunology Research | 2326-6066 | 10.1 |
Journal of Allergy and Clinical Immunology-In Practice | 2213-2198 | 9.4 |
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 1080-0549 | 9.1 |
CLINICAL IMMUNOLOGY | 1521-6616 | 8.6 |
Mucosal Immunology | 1933-0219 | 8 |
SEMINARS IN IMMUNOLOGY | 1044-5323 | 7.8 |
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 1684-1182 | 7.4 |
EXERCISE IMMUNOLOGY REVIEW | 1077-5552 | 7.3 |
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 1018-9068 | 7.2 |
CURRENT OPINION IN IMMUNOLOGY | 0952-7915 | 7 |
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 1081-1206 | 5.9 |
CANCER IMMUNOLOGY IMMUNOTHERAPY | 0340-7004 | 5.8 |
Clinical & Translational Immunology | 2050-0068 | 5.8 |
EUROPEAN JOURNAL OF IMMUNOLOGY | 0014-2980 | 5.4 |
MEDICAL MICROBIOLOGY AND IMMUNOLOGY | 0300-8584 | 5.4 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY | 0125-877X | 5 |
INTERNATIONAL REVIEWS OF IMMUNOLOGY | 0883-0185 | 5 |
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 0009-9104 | 4.6 |
Source
1. https://mjl.clarivate.com/
2. https://doi.org/10.13140/RG.2.2.22948.45444
In academia, publishing articles showcases expertise and credibility. Journals with high impact factors signal significance in the field. Understanding how to gauge a journal’s impact can enhance your publication strategy. Impact factor, a key metric, reflects a journal’s influence over time. Calculating it involves dividing the number of citations by the total articles published. Assessing personal impact also matters, considering citations to your own work. This article explores the significance, methodology, and implications of impact factors, empowering academics and professionals to navigate the publishing landscape strategically and enhance their scholarly footprint.
What is Impact factor?
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate’s Web of Science.
As a journal-level metric, it is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are given the status of being more important, or carry more prestige in their respective fields, than those with lower values.
While frequently used by universities and funding bodies to decide on promotion and research proposals, it has been criticised for distorting good scientific practices [1-3].
Why is the impact factor important?
Impact factor, an index based on the frequency with which a journal’s articles are cited in scientific publications, is a putative marker of journal quality [4]. A journal’s impact factor holds immense sway over funding, submissions, and the reputation of publishers and academics. Upholding publication quality not only boosts citation rates but also enhances a journal’s ranking. High impact factor journals signal meticulous management and prestige, fostering a virtuous cycle of scholarly engagement and recognition.
How to calculate the journal impact factor?
Journal Impact Factor (JIF) is calculated by Clarivate Analytics as the average of the sum of the citations received in a given year to a journal’s previous two years of publications (linked to the journal, but not necessarily to specific publications) divided by the sum of “citable” publications in the previous two years [5].
The calculation is based on a two-year period and involves dividing the number of times articles were cited by the number of articles that are citable.
Calculation of 2010 IF of a journal:
A = the number of times articles published in 2008 and 2009 were cited by indexed journals during 2010.
B = the total number of “citable items” published in 2008 and 2009.
A/B = 2010 impact factor
The Impact Factor is reported in Journal Citation Reports (JCR)
CiteScore, which is similar to the IF but is based on a 4-year period.
Impact Factor Controversy
The impact factor (IF), widely used in academia, has sparked debate due to its limitations. It quantifies a journal’s influence based on citations received by its articles within a specific time frame (usually two years). However, critics argue that it oversimplifies research quality and favors certain fields [6]. Indeed, the fact that it is simple to understand – it is roughly the average number of citations that primary research papers published in two consecutive years gather in the following year – makes it all too easy to point out its shortcomings: the metric also includes citations to non-primary content (such as reviews and news articles); for many fields, citations accumulate slowly and thus the two-year time window seems too short; and the average number of citations per paper can be skewed by a few highly cited ones, of which high-impact journals have a big share [7]. Furthermore, a recent study found that papers published in predatory journals, which often lack rigorous peer review, have little scientific impact. Around 60% of these papers hadn’t attracted any citations at all, and less than 3% received more than 10 citations [8]. As we rethink science publishing, there’s a growing need for a broader, more-transparent suite of metrics to judge journals beyond the traditional impact factor [9]. Researchers and institutions should consider these complexities when evaluating scholarly work and avoid relying solely on impact factors for assessing journal quality.
Recent Biggest Discoveries and advances in Immunology (2024)
- Gene-Editing Treatment for Sickle-Cell Disease:
-
- Sickle-cell disease is the first illness to be successfully treated using CRISPR gene editing technology. Patients with sickle-cell disease have two faulty copies of a gene responsible for making hemoglobin, leading to symptoms like intense pain and a reduced life expectancy.
- Researchers discovered that a simple DNA edit to bone marrow cells could turn on an alternative way to produce hemoglobin. After editing, nearly all patients in a trial experienced pain relief.
- However, the gene-editing treatment comes with an expected price tag of $2 to $3 million, making it inaccessible for many. Vertex Pharmaceuticals, which developed the treatment, has no immediate plans to offer it in Africa, where sickle-cell disease is most common [10].
- Complex Interplay of Enzymes in Innate Immune Receptor TLR7:
-
- Researchers have deciphered the intricate interactions of various enzymes around the innate immune receptor toll-like receptor 7 (TLR7). TLR7 plays a crucial role in defending our bodies against infections and diseases [11].
- Technological Advances in Immunology:
-
- The 2nd Euro-Global Summit on Advances in Clinical and Cellular Immunology highlighted several technological advancements that could shape the future of immunology:
- Precision Immunotherapy: Tailoring treatments to individual patients based on their immune profiles.
- Single-Cell Analysis: Studying individual immune cells to understand their behavior.
- Artificial Intelligence (AI): Using AI algorithms to analyze complex immunological data.
- Next-Generation Sequencing (NGS): Enhancing our ability to sequence and analyze immune-related genes.
- Nanotechnology: Developing targeted drug delivery systems.
- 3D Printing: Creating customized implants or tissues for immunotherapy.
- Advanced Imaging Techniques: Visualizing immune responses at a cellular level.
- Synthetic Biology: Designing novel immune-based therapies.
- Microfluidics and Biomaterials: Improving diagnostics and treatments [12-13].
- The 2nd Euro-Global Summit on Advances in Clinical and Cellular Immunology highlighted several technological advancements that could shape the future of immunology:
References
- Waltman L, Traag VA (1 March 2021). “Use of the journal impact factor for assessing individual articles: Statistically flawed or not?”. F1000Research. 9: 366. doi:10.12688/f1000research.23418.2
- Curry S (February 2018). “Let’s move beyond the rhetoric: it’s time to change how we judge research”. Nature. 554 (7691): 147. Bibcode:2018Natur.554..147C. doi:10.1038/d41586-018-01642-w
- Hutchins, BI; Yuan, X; Anderson, JM; Santangelo, GM (September 2016). “Relative Citation Ratio (RCR): A New Metric That Uses Citation Rates to Measure Influence at the Article Level”. PLOS Biology. 14 (9): e1002541. doi:10.1371/journal.pbio.1002541
- Saha S, Saint S, Christakis DA. Impact factor: a valid measure of journal quality? J Med Libr Assoc. 2003 Jan;91(1):42-6. PMID: 12572533; PMCID: PMC141186.
- Measuring a journal’s impact. https://www.elsevier.com/en-in/researcher/author/tools-and-resources/measuring-a-journals-impact
- The impact-factors debate: the ISI’s uses and limits – Nature. https://www.nature.com/articles/415731a.pdf.
- The diversifying nature of impact – Springer Nature. https://media.springernature.com/full/springer-cms/rest/v1/content/16138586/data/v2.
- Chawla, Dalmeet Singh. “Predatory-journal papers have little scientific impact.” Nature(2020). https://www.nature.com/articles/d41586-020-00031-6
- Wouters, P., Sugimoto, C. R., Larivière, V., McVeigh, M. E., Pulverer, B., de Rijcke, S., & Waltman, L. (2019). Rethinking impact factors: better ways to judge a journal. Nature, 569(7758), 621-623. https://www.nature.com/articles/d41586-019-01643-3
- Simon Milling, Discovery Immunology 2023. Highlights from our first full year, Discovery Immunology, Volume 2, Issue 1, 2023, kyad019, https://doi.org/10.1093/discim/kyad019
- Advance articles | Discovery Immunology | Oxford Academic. https://academic.oup.com/discovimmunology/advance-articles
- Insights in Viral Immunology: 2021 | Frontiers Research Topic. https://www.frontiersin.org/research-topics/23641/insights-in-viral-immunology-2021
- Li, T., Niu, M., Zhang, W., Qin, S., Zhou, J., & Yi, M. (2024). CAR-NK cells for cancer immunotherapy: recent advances and future directions. Frontiers in Immunology, 15, 1361194. https://doi.org/10.3389/fimmu.2024.1361194
Last update: 04-May-2024